Investigating the efficacy and safety of existing drugs in patients with rare immune diseases

Corvus Phar­ma­ceu­ti­cals said that its T cell lym­phoma drug helped shrink tu­mors in pa­tients whose can­cer had re­lapsed, ac­cord­ing to an ear­ly cut of da­ta

In its sec­ond deal an­nounced Wednes­day morn­ing, Roche’s Genen­tech is sign­ing up with Ori­o­n­is Bio­sciences for a mol­e­c­u­lar glue part­ner­ship in can­cer and neu­rode­gen­er­a­tion. Genen­tech